Q&A: Should you trust trending peptide injections? Analysis: The peptide problem: Hype is outrunning the evidence McMaster News Is the lack of human data in BPC 157 a red flag? If a drug could actually knit torn tendons back together in weeks, a trillion dollar pharmaceutical industry probably wouldn't bury When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Peptides Lack Reliable Safety Information, Watchdog Warns The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York